Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
2.150
-0.130 (-5.70%)
At close: May 30, 2025, 4:00 PM
2.180
+0.030 (1.39%)
After-hours: May 30, 2025, 7:16 PM EDT

Aldeyra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
129297206408232266
Upgrade
Market Cap Growth
78.27%43.92%-49.34%75.40%-12.74%63.98%
Upgrade
Enterprise Value
5424079260132210
Upgrade
Last Close Price
2.154.993.516.964.006.86
Upgrade
PB Ratio
2.034.181.722.701.134.47
Upgrade
P/TBV Ratio
2.024.181.722.701.134.47
Upgrade
Debt / Equity Ratio
0.250.220.130.110.080.26
Upgrade
Quick Ratio
6.365.446.4211.568.904.26
Upgrade
Current Ratio
6.495.606.6411.7919.776.69
Upgrade
Return on Equity (ROE)
-65.19%-58.54%-27.73%-34.77%-43.56%-69.81%
Upgrade
Return on Assets (ROA)
-32.60%-29.71%-16.23%-18.91%-22.20%-27.28%
Upgrade
Return on Capital (ROIC)
-36.71%-33.89%-17.68%-20.16%-23.71%-31.48%
Upgrade
Earnings Yield
-44.81%-18.80%-18.18%-15.22%-24.86%-14.10%
Upgrade
FCF Yield
-35.49%-14.54%-14.69%-13.90%-18.32%-14.08%
Upgrade
Buyback Yield / Dilution
-0.85%-0.92%-0.92%-8.08%-59.11%-25.28%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q